HAE
#1390
Haemonetics Corporation Common Stock
103.9 0 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.13%
Monthly Change
+23.38%
6 month change
+64.63%
Year Change
+103.25%
Previous Close
105.0 9
Open
104.0 3
Low
103.5 7
High
104.4 1
Volume
320
Financials
- Market Capitalization 4.73 B
- Employee 3 009
- Founded 1971
- CEO Christopher Simon
- Website www.haemonetics.com
- Headquarter Massachusetts, United States
- FIGI BBG000C7TF41
- Industry Medical Instruments & Supplies
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.8
Price to sales ratio
1.95
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1233 |  TFX Teleflex Incorporated Common Stock | 139.68 USD | +1.45% | +0.17% | +5.51% | +11.17% | 5.92 B USD | ||
| 1298 |  MMSI Merit Medical Systems, Inc. - Common Stock | 90.49 USD | +1.06% | -0.56% | +11.72% | +9.39% | 5.40 B USD | ||
| 1444 |  ICUI ICU Medical, Inc. - Common Stock | 175.10 USD | 0.00% | -4.89% | +4.40% | +41.56% | 4.38 B USD | ||
| 1450 |  NVST Envista Holdings Corporation Common Stock | 27.14 USD | -1.09% | -3.11% | -3.07% | +31.62% | 4.36 B USD |
Frequently asked questions about Haemonetics Corporation
What is the Haemonetics Corporation stock price today?
The current price of Haemonetics Corporation (HAE) is 103.90. Over the past 24 hours, the stock has changed by -1.13%. Follow the HAE chart for real-time price dynamics.
What is the stock ticker of Haemonetics Corporation?
Haemonetics Corporation trades under the ticker HAE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Haemonetics Corporation stock going up?
HAE has changed by -3.77% over the last week, +23.38% over the last month, and +103.25% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Haemonetics Corporation?
Haemonetics Corporation currently has a market capitalization of 4.73 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Haemonetics Corporation earnings last quarter?
Last quarter, Haemonetics Corporation reported earnings of 0.73 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Haemonetics Corporation revenue for the last quarter?
Haemonetics Corporation reported quarterly revenue of 339.38 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Haemonetics Corporation net income for the last quarter?
Haemonetics Corporation reported net income of 33.01 M for the last quarter. The previous quarter showed -20.15 M, which means net income changed by +263.85%.
How many employees does Haemonetics Corporation have?
As of the latest available data, Haemonetics Corporation has 3 009 employees. Workforce size can provide additional context about the company's scale and operations.
What is Haemonetics Corporation EBITDA?
Haemonetics Corporation EBITDA is 84.66 M, and its EBITDA margin is 24.94%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Haemonetics Corporation stock?
You can buy Haemonetics Corporation (HAE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Haemonetics Corporation stock?
Investing in Haemonetics Corporation requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HAE chart and related analysis on metatrader.com as part of your research.